CN103698525A - 一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅰ检测试剂盒 - Google Patents
一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅰ检测试剂盒 Download PDFInfo
- Publication number
- CN103698525A CN103698525A CN201410010750.7A CN201410010750A CN103698525A CN 103698525 A CN103698525 A CN 103698525A CN 201410010750 A CN201410010750 A CN 201410010750A CN 103698525 A CN103698525 A CN 103698525A
- Authority
- CN
- China
- Prior art keywords
- propepsin
- damping fluid
- antibody
- human
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 84
- 210000001268 chyle Anatomy 0.000 title claims abstract description 71
- 239000004816 latex Substances 0.000 title claims abstract description 67
- 229920000126 latex Polymers 0.000 title claims abstract description 67
- 108010047320 Pepsinogen A Proteins 0.000 title claims abstract description 10
- 210000002966 serum Anatomy 0.000 claims abstract description 43
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 39
- 239000002245 particle Substances 0.000 claims abstract description 23
- 238000013016 damping Methods 0.000 claims description 61
- 239000012530 fluid Substances 0.000 claims description 61
- 238000000034 method Methods 0.000 claims description 45
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 14
- 102000036639 antigens Human genes 0.000 claims description 14
- 108091007433 antigens Proteins 0.000 claims description 14
- 239000003792 electrolyte Substances 0.000 claims description 14
- -1 antiseptic Substances 0.000 claims description 12
- 235000002639 sodium chloride Nutrition 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000003381 stabilizer Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 10
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 10
- 230000002421 anti-septic effect Effects 0.000 claims description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 238000010382 chemical cross-linking Methods 0.000 claims description 7
- 239000003431 cross linking reagent Substances 0.000 claims description 7
- 125000000524 functional group Chemical group 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 241000272525 Anas platyrhynchos Species 0.000 claims description 6
- 206010070834 Sensitisation Diseases 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000008313 sensitization Effects 0.000 claims description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 5
- 239000007995 HEPES buffer Substances 0.000 claims description 5
- 102000004882 Lipase Human genes 0.000 claims description 5
- 108090001060 Lipase Proteins 0.000 claims description 5
- 239000004367 Lipase Substances 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 5
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 5
- 210000001124 body fluid Anatomy 0.000 claims description 5
- 239000010839 body fluid Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 235000019421 lipase Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 5
- 239000008363 phosphate buffer Substances 0.000 claims description 5
- 229920002223 polystyrene Polymers 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- 239000008118 PEG 6000 Substances 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 4
- 238000003763 carbonization Methods 0.000 claims description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 4
- 206010017758 gastric cancer Diseases 0.000 claims description 4
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 claims description 4
- 150000002466 imines Chemical class 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- ZNJHFNUEQDVFCJ-UHFFFAOYSA-M sodium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OCCN1CCN(CCS(O)(=O)=O)CC1 ZNJHFNUEQDVFCJ-UHFFFAOYSA-M 0.000 claims description 4
- 201000011549 stomach cancer Diseases 0.000 claims description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 3
- 241000287828 Gallus gallus Species 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- CCMKPCBRNXKTKV-UHFFFAOYSA-N 1-hydroxy-5-sulfanylidenepyrrolidin-2-one Chemical compound ON1C(=O)CCC1=S CCMKPCBRNXKTKV-UHFFFAOYSA-N 0.000 claims description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 claims description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 claims description 2
- 241000283707 Capra Species 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 235000017858 Laurus nobilis Nutrition 0.000 claims description 2
- 239000007993 MOPS buffer Substances 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 2
- 244000125380 Terminalia tomentosa Species 0.000 claims description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- NGPGYVQZGRJHFJ-UHFFFAOYSA-N chembl1604790 Chemical compound OC1=CC(O)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1 NGPGYVQZGRJHFJ-UHFFFAOYSA-N 0.000 claims description 2
- 229960000633 dextran sulfate Drugs 0.000 claims description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 2
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 229920000151 polyglycol Polymers 0.000 claims description 2
- 239000010695 polyglycol Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 claims description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 37
- 238000006243 chemical reaction Methods 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 10
- 230000004520 agglutination Effects 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract 3
- 101710198144 Endopolygalacturonase I Proteins 0.000 description 39
- 101710191566 Probable endopolygalacturonase I Proteins 0.000 description 39
- 238000012360 testing method Methods 0.000 description 30
- 238000002835 absorbance Methods 0.000 description 26
- 108090000790 Enzymes Proteins 0.000 description 19
- 102000004190 Enzymes Human genes 0.000 description 19
- 229940088598 enzyme Drugs 0.000 description 19
- 239000002872 contrast media Substances 0.000 description 18
- 108010092028 endopolygalacturonase II Proteins 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 13
- 238000002965 ELISA Methods 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- 206010018910 Haemolysis Diseases 0.000 description 7
- 210000001156 gastric mucosa Anatomy 0.000 description 7
- 230000008588 hemolysis Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 206010023126 Jaundice Diseases 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003547 immunosorbent Substances 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 238000009739 binding Methods 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000010219 correlation analysis Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 241000723353 Chrysanthemum Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000465 brunner gland Anatomy 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000091 mucous neck cell Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96472—Aspartic endopeptidases (3.4.23)
- G01N2333/96475—Aspartic endopeptidases (3.4.23) with definite EC number
- G01N2333/96477—Pepsin (3.4.23.1; 3.4.23.2; 3.4.23.3)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410010750.7A CN103698525B (zh) | 2014-01-09 | 2014-01-09 | 一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅰ检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410010750.7A CN103698525B (zh) | 2014-01-09 | 2014-01-09 | 一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅰ检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103698525A true CN103698525A (zh) | 2014-04-02 |
CN103698525B CN103698525B (zh) | 2015-10-14 |
Family
ID=50360124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410010750.7A Active CN103698525B (zh) | 2014-01-09 | 2014-01-09 | 一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅰ检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103698525B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104655843A (zh) * | 2014-05-19 | 2015-05-27 | 宁波普瑞柏生物技术有限公司 | 一种胃癌检测方法、试剂以及其试剂盒 |
CN105067815A (zh) * | 2015-09-16 | 2015-11-18 | 浙江凯成生物科技有限公司 | 一种测定人血清中胃蛋白酶原i/ii含量的试剂盒 |
CN105223348A (zh) * | 2014-05-26 | 2016-01-06 | 北京九强生物技术股份有限公司 | 人抗凝血酶iii的胶乳增强免疫比浊法检测试剂盒 |
CN107942081A (zh) * | 2018-01-12 | 2018-04-20 | 三诺生物传感股份有限公司 | 一种脂蛋白检测试剂盒 |
CN109406771A (zh) * | 2018-10-26 | 2019-03-01 | 安徽大千生物工程有限公司 | 胱抑素c胶乳增强比浊法检测试剂盒及其制备使用方法 |
CN109975545A (zh) * | 2019-03-22 | 2019-07-05 | 芜湖森爱驰生物科技有限公司 | 一种高准确性胃蛋白酶原ⅱ检测试剂盒 |
CN110609002A (zh) * | 2018-12-29 | 2019-12-24 | 深圳迈瑞生物医疗电子股份有限公司 | 一种干扰检测方法及样本分析仪 |
CN110736846A (zh) * | 2018-07-20 | 2020-01-31 | 上海练佰生物技术中心 | 一种小而密脂蛋白的测定试剂、方法和试剂盒 |
CN112229995A (zh) * | 2020-09-30 | 2021-01-15 | 北京安图生物工程有限公司 | 胃蛋白酶原pgi/ii复合校准品的稀释液及其应用 |
CN112255405A (zh) * | 2020-10-27 | 2021-01-22 | 中拓医学检验有限公司 | 一种稳定的血清胃蛋白酶原ⅰ测定试剂盒及其制备方法和应用 |
CN112763731A (zh) * | 2020-12-29 | 2021-05-07 | 广州市伊川生物科技有限公司 | 一种脂蛋白(a)测定试剂盒及其检测方法 |
CN112816698A (zh) * | 2019-11-18 | 2021-05-18 | 广东菲鹏生物有限公司 | 提高检测临床相关性的缓冲试剂和胶乳免疫比浊试剂盒 |
CN112881691A (zh) * | 2020-12-24 | 2021-06-01 | 杭州百殷生物科技有限公司 | 一种用于宫颈癌辅助诊断的免疫细胞化学标记显色试剂盒 |
CN113687079A (zh) * | 2020-05-19 | 2021-11-23 | 常州爱复康生物科技有限公司 | 一种胃蛋白酶原ⅰ胶乳免疫比浊法检测试剂盒及其制备方法 |
CN114924079A (zh) * | 2022-03-29 | 2022-08-19 | 北京世纪沃德生物科技有限公司 | 一种抗谷氨酸脱羧酶抗体测定试剂盒及检测方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006071574A (ja) * | 2004-09-06 | 2006-03-16 | Denka Seiken Co Ltd | 免疫比濁法及びそのための試薬 |
CN101957363A (zh) * | 2010-09-13 | 2011-01-26 | 南京卡博生物科技有限公司 | 胶乳免疫比浊检测用样本处理液 |
CN102628864A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定血清或尿液中心脏型脂肪酸结合蛋白的试剂盒 |
CN102645537A (zh) * | 2012-04-26 | 2012-08-22 | 北京美康生物技术研究中心 | 用于诊断胃病或胃癌的胶乳增强免疫比浊试剂盒及其制备方法和应用 |
-
2014
- 2014-01-09 CN CN201410010750.7A patent/CN103698525B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006071574A (ja) * | 2004-09-06 | 2006-03-16 | Denka Seiken Co Ltd | 免疫比濁法及びそのための試薬 |
CN101957363A (zh) * | 2010-09-13 | 2011-01-26 | 南京卡博生物科技有限公司 | 胶乳免疫比浊检测用样本处理液 |
CN102628864A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定血清或尿液中心脏型脂肪酸结合蛋白的试剂盒 |
CN102645537A (zh) * | 2012-04-26 | 2012-08-22 | 北京美康生物技术研究中心 | 用于诊断胃病或胃癌的胶乳增强免疫比浊试剂盒及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
弓福利等: "一种有效去除脂血对血清多种生化指标测定干扰的方法", 《实用医技杂志》 * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104655843A (zh) * | 2014-05-19 | 2015-05-27 | 宁波普瑞柏生物技术有限公司 | 一种胃癌检测方法、试剂以及其试剂盒 |
CN105223348A (zh) * | 2014-05-26 | 2016-01-06 | 北京九强生物技术股份有限公司 | 人抗凝血酶iii的胶乳增强免疫比浊法检测试剂盒 |
CN105067815A (zh) * | 2015-09-16 | 2015-11-18 | 浙江凯成生物科技有限公司 | 一种测定人血清中胃蛋白酶原i/ii含量的试剂盒 |
CN107942081A (zh) * | 2018-01-12 | 2018-04-20 | 三诺生物传感股份有限公司 | 一种脂蛋白检测试剂盒 |
CN107942081B (zh) * | 2018-01-12 | 2020-09-18 | 三诺生物传感股份有限公司 | 一种脂蛋白检测试剂盒 |
CN110736846A (zh) * | 2018-07-20 | 2020-01-31 | 上海练佰生物技术中心 | 一种小而密脂蛋白的测定试剂、方法和试剂盒 |
CN110736846B (zh) * | 2018-07-20 | 2023-07-14 | 上海微鸿企业管理有限公司 | 一种小而密脂蛋白的测定试剂、方法和试剂盒 |
CN109406771A (zh) * | 2018-10-26 | 2019-03-01 | 安徽大千生物工程有限公司 | 胱抑素c胶乳增强比浊法检测试剂盒及其制备使用方法 |
CN109406771B (zh) * | 2018-10-26 | 2023-04-07 | 安徽大千生物工程有限公司 | 胱抑素c胶乳增强比浊法检测试剂盒及其制备使用方法 |
CN110609002A (zh) * | 2018-12-29 | 2019-12-24 | 深圳迈瑞生物医疗电子股份有限公司 | 一种干扰检测方法及样本分析仪 |
CN109975545A (zh) * | 2019-03-22 | 2019-07-05 | 芜湖森爱驰生物科技有限公司 | 一种高准确性胃蛋白酶原ⅱ检测试剂盒 |
CN112816698A (zh) * | 2019-11-18 | 2021-05-18 | 广东菲鹏生物有限公司 | 提高检测临床相关性的缓冲试剂和胶乳免疫比浊试剂盒 |
CN113687079A (zh) * | 2020-05-19 | 2021-11-23 | 常州爱复康生物科技有限公司 | 一种胃蛋白酶原ⅰ胶乳免疫比浊法检测试剂盒及其制备方法 |
CN112229995A (zh) * | 2020-09-30 | 2021-01-15 | 北京安图生物工程有限公司 | 胃蛋白酶原pgi/ii复合校准品的稀释液及其应用 |
CN112255405A (zh) * | 2020-10-27 | 2021-01-22 | 中拓医学检验有限公司 | 一种稳定的血清胃蛋白酶原ⅰ测定试剂盒及其制备方法和应用 |
CN112881691A (zh) * | 2020-12-24 | 2021-06-01 | 杭州百殷生物科技有限公司 | 一种用于宫颈癌辅助诊断的免疫细胞化学标记显色试剂盒 |
CN112763731A (zh) * | 2020-12-29 | 2021-05-07 | 广州市伊川生物科技有限公司 | 一种脂蛋白(a)测定试剂盒及其检测方法 |
CN112763731B (zh) * | 2020-12-29 | 2023-02-28 | 广州市伊川生物科技有限公司 | 一种脂蛋白(a)测定试剂盒及其检测方法 |
CN114924079A (zh) * | 2022-03-29 | 2022-08-19 | 北京世纪沃德生物科技有限公司 | 一种抗谷氨酸脱羧酶抗体测定试剂盒及检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103698525B (zh) | 2015-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103698525B (zh) | 一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅰ检测试剂盒 | |
CN103713140B (zh) | 一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅱ检测试剂盒 | |
CN102662061B (zh) | 胶乳增强免疫比浊法测定人甲胎蛋白含量的试剂盒 | |
CN108303544A (zh) | 一种全血c反应蛋白检测试剂盒 | |
CN109596843B (zh) | 一种血清淀粉样蛋白a的测定试剂盒 | |
CN112526134A (zh) | 一种壳多糖酶3样蛋白1测定试剂盒 | |
CN106198415A (zh) | 一种测定糖化血红蛋白的试剂盒及其制备方法 | |
EP0064274B1 (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
CN104749375A (zh) | 人血清中c肽含量的检测方法及其用试剂盒和试剂盒的制备方法 | |
CN103852584A (zh) | 一种定量检测c肽的胶乳增强免疫比浊试剂盒 | |
CN102662064A (zh) | 检测中性粒细胞明胶酶相关脂质运载蛋白的免疫比浊试剂盒及其制备方法 | |
CN105223365A (zh) | Gp73胶乳增强免疫比浊法体外定量测定诊断试剂盒 | |
CN105067815A (zh) | 一种测定人血清中胃蛋白酶原i/ii含量的试剂盒 | |
CN105223348A (zh) | 人抗凝血酶iii的胶乳增强免疫比浊法检测试剂盒 | |
CN107607729A (zh) | 一种胶乳增强免疫比浊法检测脂蛋白(a)的试剂盒及制备方法 | |
CN109307766A (zh) | 胃蛋白酶原ⅰ检测试剂盒 | |
CN109188000A (zh) | 一种便携式检测人甲状旁腺激素的试纸条及其制备方法 | |
CN111596072A (zh) | 一种基于胶乳增强免疫比浊法测定pth的试剂盒及其制备使用方法 | |
CN107942068B (zh) | β2-微球蛋白测定试剂盒 | |
CN107490677A (zh) | 一种羧基胶乳微球与糖化血红蛋白抗体的交联组合液及其交联方法 | |
NO159619B (no) | Immunokjemisk enzymbestemmelse. | |
CN106461662A (zh) | 肌酸激酶mb同工酶的测定方法以及其中使用的试剂盒 | |
CN102341707B (zh) | 检测试剂以及使用该检测试剂测定检测样品中的被测定物的方法 | |
CN107991500A (zh) | 糖化血红蛋白检测试剂盒 | |
CN101446586A (zh) | 免疫分析试剂和分析方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xue Inventor after: Liu Hongchun Inventor after: Liu Min Inventor after: OuYang Zhuojun Inventor before: Li Xue Inventor before: Liu Hongchun Inventor before: OUYANG ZHUOJUN |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI XUE LIU HONGCHUN OUYANG ZHUOJUN TO: LI XUE LIU HONGCHUN LIU MIN OUYANG ZHUOJUN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A latex immunoturbidimetric pepsinogen I detection kit for eliminating chyle interference Effective date of registration: 20231222 Granted publication date: 20151014 Pledgee: Zhongguancun Branch of Bank of Beijing Co.,Ltd. Pledgor: BEIJING WANTAI DRD CO.,LTD. Registration number: Y2023110000546 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |